Glaxosmithkline reported GBP3.36B in EBITDA for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Amgen AMGN:US USD 3.5B 62M
AstraZeneca AZN:LN USD 3.6B 404M
Aurora Cannabis Inc ACB:CN CAD -63067000 2.66M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Canopy Growth Corp WEED:CN CAD -95980000 11.78M
Catalent CTLT:US USD 161M 200M
Corcept Therapeutics CORT:US USD 32.13M 581K
Eli Lilly And LLY:US USD 2.31B 308.9M
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Glaxosmithkline GSK:US GBP 3.36B 916M
JAZZ PHA JAZZ:US USD 348.04M 65.49M
Johnson & Johnson JNJ:US USD 7.81B 876M
Lannett LCI:US USD -10082000 6.25M
Novartis NOVN:VX USD 4.69B 34M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Perrigo Ordinary Shares PRGO:US USD 140.7M 54.6M
Pfizer PFE:US USD 10.52B 2.78B
Prestige Brands PBH:US USD 92.63M 2.77M
Takeda 4502:JP JPY 272.27B 36.53B
Teva Pharmaceutical TEVA:IT USD 1.06B 31M
Valeant Pharmaceuticals VRX:CN USD 713M 80M
Zoetis ZTS:US USD 840M 14M